| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000272755.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.007751679 |
Resistant |
| ENSG00000272755.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002518161 |
Resistant |
| ENSG00000272755.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.006715737 |
Resistant |
| ENSG00000272755.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.004320598 |
Resistant |
